UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: April 20, 2023 4:15 P.M.
Form: S-4
CIK: 0001621227
Company Name: Adaptimmune Therapeutics PLC
File Number: 333-271145